Clearmind Signs Development and Supply Agreement to Produce its Drug Candidate MEAI Psychedelic Molecule With Aragen Life Sciences

Clearmind Medicine Inc. announced it has entered into a Development and Supply agreement with Aragen Life Sciences Pvt. Ltd (Aragen) for the production of its innovative molecule, 5-Methoxy-2-aminoindane (MEAI).

Category Press Release
?>